SunBio

067370 · KOSDAQ · ₩067370 · 선바이오

₩5,680▲ ₩60 (1.07%)End-of-day · Oct 28, 2026 · End-of-day prices.
Trade
Alert me

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩2.2B₩1.3B₩4.7B₩4.2B₩1.7B₩3B₩3.4B₩1.8B
Cost of sales₩1.2B₩71M₩1.9B₩1.7B₩606M₩1.1B₩691M₩406M
Gross profit₩1B₩1.2B₩2.8B₩2.5B₩1.1B₩1.9B₩2.7B₩1.4B
Operating income₩284M₩458M₩2.1B₩1.6B₩118M₩1.2B₩1.5B−₩142M
Net income₩631M₩318M₩2.1B₩1.3B−₩1.2B₩616M₩1.6B−₩469M
Net income to shareholders₩631M₩318M₩2.1B₩1.3B−₩1.2B₩616M₩1.6B−₩469M

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩64B₩62B₩61B₩59B₩59B₩61B₩61B₩59B
Current assets₩16B₩13B₩11B₩9.6B₩8.6B₩12B₩13B₩9.9B
Cash and equivalents₩3.9B₩5.4B₩2.8B₩3.1B₩3.1B₩3.6B₩6.2B₩4.8B
Total liabilities₩34B₩33B₩32B₩33B₩33B₩34B₩34B₩33B
Current liabilities₩34B₩32B₩21B₩22B₩23B₩23B₩17B₩17B
Borrowings₩29B₩29B₩18B₩18B₩18B₩20B₩14B₩29B
Total equity₩30B₩29B₩29B₩27B₩26B₩28B₩27B₩26B
Shareholders' equity₩30B₩29B₩29B₩27B₩26B₩28B₩27B₩26B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩1.3B₩1.8B−₩523M₩3B₩1.3B−₩27M₩1.9B−₩1.1B
Capital spending₩324M₩8.8M−₩31M₩1.5B₩275M₩1.5B₩1.6B₩4.7B
Free cash flow−₩1.6B₩1.8B−₩554M₩1.5B₩1.1B−₩1.5B₩292M−₩5.8B
Dividends paid——₩0₩0——₩1.8B−₩1.8B

Consolidated where available. Amounts in won.

Also known as: SunBio / 선바이오 / 067370 / KRX:067370

Source: KRX statistical information